Kaplan-Meier analysis of atotal of 492 patients with prostate cancer showed that patients with high BAP1expression had worse disease-free survival compared with that of patients withrelatively low BAP1 expression (p < 0.01, log-rank test)(Figure 1C). This evidence concerns the gene BAP1 and prostate carcinoma.